Brief: Mediwound Awarded Additional $3.3 Million From U.S. Department Of War To Advance Room-Temperature-Stable Formulation Of Nexobrid
22/09/2026 12:08
BRIEF-Mediwound Awarded Additional $3.3 Million From U.S. Department Of War To Advance Room-Temperature-Stable Formulation Of Nexobrid Sept 22 (Reuters) - Mediwound Ltd MDWD.O:
MEDIWOUND AWARDED ADDITIONAL $3.3 MILLION FROM U.S. DEPARTMENT OF WAR TO ADVANCE ROOM-TEMPERATURE-STABLE FORMULATION OF NEXOBRID®
MEDIWOUND - TOTAL PROGRAM BUDGET FOR NEXOBRID DEVELOPMENT RAISED TO $21.80 MILLION
Source text: ID:nGNX6VYtNP
Further company coverage: MDWD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mediwound
See all newsBrief: Mediwound Awarded Additional $3.3 Million From U.S. Department Of War To Advance Room-Temperature-Stable Formulation Of Nexobrid
Mediwound Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's MediWound beats Q2 revenue estimates, reaffirms 2026 guidance
Brief: MediWound Q2 EPS USD -0.57
Mediwound Ltd expected to post a loss of 76 cents a share - Earnings Preview